In the present study, RECK expression in peripheral T-cell lymphoma (PTCL; n=82) was examined using immunohistochemistry, and its correlation with clinicopathological factors was analyzed. This evidence concerns the gene RECK and peripheral T-cell lymphoma, not otherwise specified.